IFM Investors Pty Ltd Raises Holdings in Xylem Inc. (NYSE:XYL)

IFM Investors Pty Ltd boosted its stake in shares of Xylem Inc. (NYSE:XYLGet Rating) by 16.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,905 shares of the industrial products company’s stock after purchasing an additional 3,910 shares during the quarter. IFM Investors Pty Ltd’s holdings in Xylem were worth $2,379,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC acquired a new position in shares of Xylem during the 4th quarter worth about $1,735,000. Commonwealth Equity Services LLC boosted its position in shares of Xylem by 1.6% during the 4th quarter. Commonwealth Equity Services LLC now owns 42,446 shares of the industrial products company’s stock worth $5,090,000 after acquiring an additional 685 shares in the last quarter. Yousif Capital Management LLC acquired a new position in shares of Xylem during the 4th quarter worth about $3,225,000. CWM LLC acquired a new position in shares of Xylem during the 4th quarter worth about $195,000. Finally, Qube Research & Technologies Ltd acquired a new position in shares of Xylem during the 4th quarter worth about $17,019,000. Hedge funds and other institutional investors own 83.83% of the company’s stock.

Xylem Price Performance

XYL stock opened at $97.22 on Friday. Xylem Inc. has a 52-week low of $72.08 and a 52-week high of $138.78. The stock has a market capitalization of $17.51 billion, a price-to-earnings ratio of 41.91, a price-to-earnings-growth ratio of 3.19 and a beta of 1.11. The company has a quick ratio of 1.21, a current ratio of 1.63 and a debt-to-equity ratio of 0.59. The stock’s fifty day simple moving average is $81.89 and its 200-day simple moving average is $86.08.

Xylem (NYSE:XYLGet Rating) last released its quarterly earnings data on Tuesday, August 2nd. The industrial products company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.54 by $0.12. Xylem had a return on equity of 13.66% and a net margin of 8.06%. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period last year, the company posted $0.66 earnings per share. The firm’s revenue was up 1.0% compared to the same quarter last year. Equities research analysts expect that Xylem Inc. will post 2.54 EPS for the current year.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 23rd. Stockholders of record on Thursday, May 26th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date of this dividend was Wednesday, May 25th. Xylem’s payout ratio is 51.72%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Citigroup upped their price objective on Xylem from $84.00 to $95.00 and gave the stock a “neutral” rating in a research report on Wednesday. The Goldman Sachs Group upped their price objective on Xylem from $87.00 to $99.00 and gave the stock a “neutral” rating in a research report on Wednesday. Morgan Stanley lowered their price objective on Xylem from $110.00 to $100.00 and set an “overweight” rating for the company in a research report on Thursday, June 9th. Cowen raised Xylem from a “market perform” rating to an “outperform” rating in a research report on Wednesday, June 1st. Finally, Mizuho upped their target price on Xylem from $80.00 to $88.00 and gave the company a “neutral” rating in a research report on Wednesday. Ten analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $102.30.

Insider Transactions at Xylem

In other news, SVP Hayati Yarkadas sold 2,082 shares of Xylem stock in a transaction dated Tuesday, June 21st. The stock was sold at an average price of $74.18, for a total transaction of $154,442.76. Following the sale, the senior vice president now directly owns 9,556 shares of the company’s stock, valued at $708,864.08. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, SVP Hayati Yarkadas sold 2,082 shares of Xylem stock in a transaction dated Tuesday, June 21st. The stock was sold at an average price of $74.18, for a total transaction of $154,442.76. Following the sale, the senior vice president now directly owns 9,556 shares of the company’s stock, valued at $708,864.08. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Jeanne Beliveau-Dunn sold 600 shares of Xylem stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $96.65, for a total value of $57,990.00. Following the sale, the director now directly owns 7,553 shares in the company, valued at $729,997.45. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 8,655 shares of company stock valued at $691,104. 0.89% of the stock is currently owned by insiders.

Xylem Profile

(Get Rating)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.

Recommended Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLGet Rating).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.